Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment

被引：0
|
作者：
Cea, Michele
Cagnetta, Antonia [1 ]
Cirmena, Gabriella
Garuti, Anna
Rocco, Ilaria
Palermo, Claudia
Pierri, Ivana [2 ]
Gobbi, Marco [3 ]
Ballestrero, Alberto [4 ]
Nencioni, Alessio
Patrone, Franco [4 ]
Carella, Angelo Michele [5 ]
机构：
[1] Univ Genoa, Dept Hematol, Genoa, Italy
[2] Univ Genoa, Chair Hematol, Genoa, Italy
[3] Univ Genoa, Chair Haematol, Genoa, Italy
[4] Univ Genoa, Chair Internal Med, Genoa, Italy
[5] Osped San Martino Genova, Genoa, Italy
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：521 / 521
页数：1
相关论文
共 50 条
  • [41] Sonic hedgehog maintains survival and growth of chronic myeloid leukemia progenitor cells through β-catenin signaling
    Su, Wenxia
    Meng, Fankai
    Huang, Lifang
    Zheng, Miao
    Liu, Wenli
    Sun, Hanying
    EXPERIMENTAL HEMATOLOGY, 2012, 40 (05) : 418 - 427
  • [42] Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells
    Liao, Hui-Fen
    Su, Yu-Chieh
    Zheng, Zhi-Yu
    Cai, Chang Jhih
    Hou, Ming-Hung
    Chao, K. S. Clifford
    Chen, Yu-Jen
    BIOMEDICINE & PHARMACOTHERAPY, 2012, 66 (05) : 378 - 383
  • [43] Early cytogenetic and molecular response during first-line treatment of chronic myeloid leukemia in chronic phase
    Quintas-Cardama, Alfonso
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    CANCER, 2011, 117 (23) : 5261 - 5270
  • [44] CLINICAL FACTORS FOR PREDICTION OF RELAPSE AFTER DISCONTINUATION OF TREATMENT IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
    Paz, Romero Yolanda Maria
    Luna, de Abia Alejandro
    Saez, Marin Adolfo Jesus
    Nunez-Torron, Stock Claudia
    Piris, Villaespesa Miguel
    Lopez, Jimenez Francisco Javier
    Garcia, Gutierrez Valentin
    HAEMATOLOGICA, 2020, 105 : 129 - 130
  • [45] PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase
    Alonso-Dominguez, Juan M.
    Felipe Casado, Luis
    Anguita, Eduardo
    Teresa Gomez-Casares, Maria
    Buno, Ismael
    Ferrer-Marin, Francisca
    Arenas, Alicia
    Del Orbe, Rafael
    Ayala, Rosa
    Llamas, Pilar
    Salgado, Rocio N.
    Osorio, Santiago
    Sanchez-Godoy, Pedro
    Burgaleta, Carmen
    Mahillo-Fernandez, Ignacio
    Garcia-Gutierrez, Valentin
    Luis Steegmann, Juan
    Martinez-Lopez, Joaquin
    PLOS ONE, 2017, 12 (07):
  • [46] HYDROXYUREA TREATMENT FOR CHRONIC MYELOID-LEUKEMIA DURING PREGNANCY
    JACKSON, N
    SHUKRI, A
    ALI, K
    BRITISH JOURNAL OF HAEMATOLOGY, 1993, 85 (01) : 203 - 204
  • [47] Successful treatment of chronic myeloid leukemia during pregnancy with hydroxyurea
    Fadilah, SAW
    Ahmad-Zailani, H
    Soon-Keng, C
    Norlaila, M
    LEUKEMIA, 2002, 16 (06) : 1202 - 1203
  • [48] Successful treatment of chronic myeloid leukemia during pregnancy with hydroxyurea
    SAW Fadilah
    H Ahmad-Zailani
    C Soon-Keng
    M Norlaila
    Leukemia, 2002, 16 : 1202 - 1203
  • [49] Definition and treatment of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia
    Baccarani, Michele
    Castagnetti, Fausto
    Gugliotta, Gabriele
    Palandri, Francesca
    Rosti, Gianantonio
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (03) : 397 - 406
  • [50] Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia
    Blanco, JG
    Dervieux, T
    Edick, MJ
    Mehta, PK
    Rubnitz, JE
    Shurtleff, S
    Raimondi, SC
    Behm, FG
    Pui, CH
    Relling, MV
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) : 10338 - 10343
12345